Max Healthcare Institute Ltd

Max Healthcare Institute Ltd maintains a strong liquidity position, with a current ratio of 1.37, indicating the company can cover its short-term liabilities with its short-term assets. The company's liquidity_fpt score suggests a medium liquidity risk, which is consistent with its cash and equivalents of 10,992.7 million INR and long-term debt of 12,989.5 million INR. However, the company's net cash position is negative after subtracting total debt, which could pose a liquidity challenge if not managed effectively. In terms of profitability, Max Healthcare Institute Ltd reports a return on equity (ROE) of 2.99% and a return on assets (ROA) of 2.1%, which are below the industry median for healthcare facilities and services. The company's operating income of 3,112.1 million INR and net income of 2,515.4 million INR reflect a solid but not exceptional performance in a competitive sector. The gross profit margin of 79.2% is in line with industry norms, but the company's operating margin of 21.9% suggests room for improvement in cost management. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification could expose the company to regional economic or regulatory risks. The company's capital expenditures of -7,859.5 million INR indicate a significant investment in infrastructure or expansion, which may support future growth but could also strain short-term cash flow. Looking ahead, the company's revenue is expected to grow, supported by its strong operating cash flow of 11,563.9 million INR. Analysts have provided a mean price target of 1,213.50 INR and a median price target of 1,254.00 INR, with a mean recommendation of 2.18, indicating a generally positive outlook. The company's growth trajectory is further supported by its strong buy and buy recommendations from analysts, with 5 and 12 such ratings, respectively. The company's risk assessment indicates a low dilution risk, with a dilution score of low. The company's capital structure, with a debt-to-equity ratio of 0.15, suggests a conservative approach to leverage, which reduces financial risk. However, the company's net cash position being negative after subtracting total debt could be a concern if not addressed. The company has not disclosed any recent dilutive events, and its shares outstanding remain unchanged between basic and diluted shares. Recent events, including analyst estimates and price targets, suggest a positive sentiment toward the company. The company's strong operating cash flow and positive analyst recommendations indicate a favorable market perception. However, the company should continue to monitor its liquidity and manage its debt effectively to maintain its strong financial position.